Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
IL-13
85 Products
85 Products
166 Diseases
10134 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
24
48
72
96
120
144
168
192
216
240
Dupixent
(dupilumab) / Sanofi, Regeneron
Adbry
(tralokinumab-ldrm) / LEO Pharma, AstraZeneca
Ebglyss
(lebrikizumab) / Eli Lilly
stapokibart
(CM310) / Keymed Biosciences
Rizaben
(tranilast) / Kissei, Nuon Therapeutics
dectrekumab
(QAX576) / Novartis
cendakimab
(CC-93538) / AbbVie, BMS
rademikibart
(CBP-201) / Suzhou Connect Biopharma
611
/ 3SBio
deuterated S-lisofylline
(PCS499) / Processa Pharma
Aerovant
(pitrakinra) / Aerovance
anrukinzumab
(IMA-638) / Pfizer
manfidokimab
(AK120) / Akesobio
eblasakimab
(ASLAN004) / ASLAN Pharma, Zenyaku Holdings
AR100
/ ARJIL Pharma
GSK679586
/ GSK
IMA 026
/ Pfizer
MB-101
/ Fortress
NuGel
(taurodeoxycholic acid) / Shaperon
QBX-258
/ Novartis
romilkimab
(SAR156597) / Sanofi
AIR645
/ Ionis
ICT-107
/ Targepeutics, EOM Pharma
PF-07264660
/ Pfizer
SL-701
/ Menarini
lunsekimig
(SAR443765) / Sanofi
AMG 317
/ Amgen
BA2101
/ Luye Group
BITS7201A
/ Roche
CLM-103
/ CellabMed
CNTO 5825
/ J&J
GSK2434735
/ GSK
IL-13Rα2 UCAR-T cell therapy
/ Suzhou Maximum Bio-tech
NM26
/ Numab, Kaken Pharma
QAX-567
/ Novartis
R256
/ AstraZeneca
SNC109
/ Shanghai Simnova Bio
TmEGFR/IL13Rα2 01 CAR-T
/ Gilead
abrezekimab
(VR942) / Vectura, UCB
hypochlorous acid
(PR022) / ESSA Pharma